Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below.
If a full report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02413398”
into the search box and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click
“Home & Search”. Then, type “2015-000804-24” in the search box
and click “Search”.
Official study title: A Multicentre, Double-Blind, Placebo-Controlled, Parallel
Group, Randomized, Phase III Study to Evaluate the Glycaemic Efficacy and
Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus and
Moderate Renal Impairment (CKD 3A) Who Have Inadequate Glycaemic Control
Protocol number: D1690C00024
AstraZeneca is the sponsor of this study and has its headquarters at
1800 Concord Pike in Wilmington, Delaware.
The phone number for the AstraZeneca Information Center is 1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part
in clinical research around the world. They help researchers answer important
health questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version: V1.2 06/2018 8